GB0024271D0 - Improved methods and compositions for pulmonary delivery of actives - Google Patents

Improved methods and compositions for pulmonary delivery of actives

Info

Publication number
GB0024271D0
GB0024271D0 GB0024271A GB0024271A GB0024271D0 GB 0024271 D0 GB0024271 D0 GB 0024271D0 GB 0024271 A GB0024271 A GB 0024271A GB 0024271 A GB0024271 A GB 0024271A GB 0024271 D0 GB0024271 D0 GB 0024271D0
Authority
GB
United Kingdom
Prior art keywords
actives
compositions
improved methods
pulmonary delivery
pulmonary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0024271A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0024271A priority Critical patent/GB0024271D0/en
Publication of GB0024271D0 publication Critical patent/GB0024271D0/en
Priority to AU2001287930A priority patent/AU2001287930A1/en
Priority to PCT/GB2001/004255 priority patent/WO2002024175A2/en
Ceased legal-status Critical Current

Links

GB0024271A 2000-09-25 2000-09-25 Improved methods and compositions for pulmonary delivery of actives Ceased GB0024271D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0024271A GB0024271D0 (en) 2000-09-25 2000-09-25 Improved methods and compositions for pulmonary delivery of actives
AU2001287930A AU2001287930A1 (en) 2000-09-25 2001-09-25 Pharmaceutical formulation for pulmonary or nasal administration
PCT/GB2001/004255 WO2002024175A2 (en) 2000-09-25 2001-09-25 Pharmaceutical formulation for pulmonary or nasal administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0024271A GB0024271D0 (en) 2000-09-25 2000-09-25 Improved methods and compositions for pulmonary delivery of actives

Publications (1)

Publication Number Publication Date
GB0024271D0 true GB0024271D0 (en) 2000-11-15

Family

ID=9900645

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0024271A Ceased GB0024271D0 (en) 2000-09-25 2000-09-25 Improved methods and compositions for pulmonary delivery of actives

Country Status (3)

Country Link
AU (1) AU2001287930A1 (en)
GB (1) GB0024271D0 (en)
WO (1) WO2002024175A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2198869B1 (en) * 2007-02-23 2015-09-16 Next 21 K.K. Trehalose for the treatment or prevention of vasospasm

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001165A1 (en) * 1986-08-11 1988-02-25 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules
EP0655237A1 (en) * 1993-11-27 1995-05-31 Hoechst Aktiengesellschaft Medicinal aerosol formulation
CA2213638C (en) * 1995-02-24 2004-05-04 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations

Also Published As

Publication number Publication date
AU2001287930A1 (en) 2002-04-02
WO2002024175A2 (en) 2002-03-28
WO2002024175A3 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
HUP0105021A3 (en) Compositions having improved delivery of actives and process for their preparation
EG24357A (en) New Pharmaceutical composition
PL351552A1 (en) Gypsum compositions and related methods
PT1318785T (en) Pulmonary delivery of l-dopa
AU4570901A (en) Biocidal methods and compositions
AU8911801A (en) Improved nanocomposite compositions and methods for making and using same
GB2385524B (en) Compositions and methods of use for extracts of magnoliaceae
AU7013501A (en) Methods and composition for oral vaccination
EP1420767A4 (en) Compositions containing itraconazole and their preparation methods
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
AU5073101A (en) Lipid composition and use thereof
EP1333825A4 (en) Method for enhanced delivery of oxybutynin and compositions thereof
IL154756A0 (en) Methods and compositions for promoting the maturation of monocytes
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
GB0117274D0 (en) Cleaning compositions and their use
IL153487A0 (en) Pharmaceutical compositions and methods for use
AU3201701A (en) Pharmaceutical composition for pulmonary delivery
IL153897A0 (en) Pharmaceutical compositions and methods for use
GB0024271D0 (en) Improved methods and compositions for pulmonary delivery of actives
AU1182402A (en) Methods and compositions for enhancing angiogenesis
GB0013503D0 (en) Pharmaceutical compositions and their uses
HUP0500956A3 (en) Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them
GB0000001D0 (en) Pharmaceutical compositions and their preparation
GB0028823D0 (en) Cleaning methods and compositions
GB0015361D0 (en) Improvements in pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)